Protalix Biotherapeutics, Inc. (PLX)
1.985
0.00 (0.00%)
USD |
NYAM |
Jun 10, 16:00
1.98
0.00 (0.00%)
After-Hours: 16:07
Protalix Biotherapeutics SG&A Expense (Quarterly) : 3.051M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Agenus, Inc. | 6.86M |
| Altimmune, Inc. | 8.052M |
| Humacyte, Inc. | 7.93M |
| Amgen, Inc. | 1.602B |
| BioCryst Pharmaceuticals, Inc. | 94.55M |